MG
THRN

Michael Gelband’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Michael Gelband’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,000
Closed -$130K – 2735
2021
Q3 		$130K Buy
+15,000
New +$122K ﹤0.01% 1870

Other funds holding THRN

DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $37.3B AUM 38.63% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

Michael Gelband's THRN Position: Q4 2021 in Review

Michael Gelband sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2021, closing a stake of 15,000 shares — an estimated $130K sold.

Michael Gelband first reported a position in THRN in Q3 2021 and held it in 1 quarter. The position peaked at $130K in Q3 2021. 52 funds tracked by Wall St. Rank hold THRN as of Q4 2021.

  • Michael Gelband reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Michael Gelband sold 15,000 Thorne Healthtech, Inc. Common Stock shares in Q4 2021, an estimated $130K.
  • Michael Gelband first reported a position in Thorne Healthtech, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Michael Gelband's Thorne Healthtech, Inc. Common Stock position peaked at $130K in Q3 2021.
  • 52 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2021.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.